Use of an animal model in studies of bacterial corneal infection

ILAR Journal

Volumn 40, Issue 2, 1999, Pages 43-50

  Cowell, Brigitte A ^a   Wu, Christine ^a   Fleiszig, Suzanne M J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001804255     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.40.2.43     Document Type: Article

References (54)

1. Andika RC, Wu C, Fleiszig SMJ. 1998. Chronic cytotoxicity induced by invasive Pseudomonas aeruginosa is invasion dependent and involves Exs A. (Abstract). Invest Ophthalmol Vis Sci 39:5143.
2. Balls M. 1994. Replacement of animal procedures: Alternatives in re-search, education and testing. Lab Anim 28:193-211.
3. Beisel KW, Hazlett LD, Berk RS. 1983. Dominant susceptibility effect on the murine corneal response to Pseudomonas aeruginosa. Proc Soc Exp Biol Med 172:488-491.
4. Berk RS. 1993. Genetic regulation of the murine corneal and non-corneal response to Pseudomonas aeruginosa. In: Campa M, Berdinelli M, Friedman H, editors. Pseudomonas aeruginosa as an Opportunistic Pathogen. New York: Plenum Press, p 186-206.
5. Berk RS, Leon MA, Hazlett LD. 1979. Genetic control of the murine corneal response to Pseudomonas aeruginosa. Infect Immun 26:1221 - 1223.
6. Berk RS, Hazlett LD, Beisel KW. 1987. Genetic studies on resistant and susceptibility genes controlling the mouse cornea response to infection with Pseudomonas aeruginosa. Antibiot Chemother 39:83-91.
7. Berk RS, Preston MJ, Montgomery IN, Hazlett LD, Tse TY. 1991. Antibody hyporesponsiveness in resistant BALB/CJ intracomeally infected with Pseudomonas aeruginosa. Reg Immunol 3:186-191.
8. Bowman RW, McCulley JP. 1994. Ocular bacteriology. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders. p 816-834.
9. Buehler PO, Schein OD, Stamler JF, Verdier DD, Katz J. 1992. The increased risk of ulcerative keratitis among disposable soft contact lens users. Arch Ophthalmol 110:1555-1558.
10. Cheng KH, Leung SL, Hoekman JW, Beekhuis WH, Geerards AJM, Kijlstra A. 1998. Incidence of contact lens-associated ulcerative keratitis and its related morbidity. (Abstract). Invest Ophthalmol Vis Sci 39:5337.
11. Ciofu O, Giwercman B, Pedersen SS, Hoiby N. 1994. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF center. Apmis 102:674-680.
12. Cole N, Willcox MDP, Fleiszig SMJ, Stapleton F, Bao B, Tout S, Husband A. 1998. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res 17:730-735.
13. Cowell BA, Willcox MDP, Schneider RP. 1997. Growth of Gram-negative bacteria in a simulated ocular environment. Aust NZ J Ophthalmol 25:S23-S26.
14. Cryz SJ Jr, Pitt TL, Fürer E, Germanier R. 1984. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 44:508-513.
15. Dartt DA. 1994. Tear physiology and biochemistry. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders. p 1043-1049.
16. Evans DJ, Frank DW, Finck-Barbaçon V, Wu C, Fleiszig SMJ. 1998. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect Immun 66:1453-1459.
17. Finck-Barbançon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SMJ, Wu C, Mende-Mueller L, Frank DW. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25:547-557.
18. Fleiszig SMJ, Fletcher EL, Lowe R. 1992. Microbiology of contact lens care. In: Bennett ES, Weissman BA, editors. Clinical Contact Lens Practice. Philadelphia: JB Lippincott. p 1-29.
19. Fleiszig SMJ, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. 1994. Pseudomonas aeruginosa invades corneal epithelial cells during experi-mental infection. Infect Immun 62:3485-3493.
20. Fleiszig SMJ, Zaidi TS, Pier GB. 1995. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun 63:4072-4077.
21. Fleiszig SMJ, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. 1996. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun 64:2288-2294.
22. Fleiszig SMJ, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE, Kanada D, Sawa T, Yen TS, Frank DW. 1997a. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 65:579-586.
23. Fleiszig SMJ, Evans DJ, Do N, Vallas V, Shin S, Mostov KE. 1997b. Epithelial cell polarity affects susceptibility to Pseudomonas aeruginosa invasion and cytotoxicity. Infect Immun 65:2861-2867.
24. Fleiszig SMJ, Lee EJ, Wu C, Andika RC, Vallas V, Portoles M, Frank DW. 1998. Cytotoxic strains of Pseudomonas aeruginosa can damage the intact corneal surface in vitro. CLAO J 24:41-47.
25. Foster CS. 1987. Eye and immunity. Antibiot Chemother 39:77-82.
26. Franklin RM. 1989. The ocular secretory immune system: A review. Curr Eye Res 8:599-606.
27. Fullard RJ, Wilson GS. 1986. Investigation of sloughed corneal epithelial cells collected by non-invasive irrigation of the corneal surface. Curr Eye Res 5:847-856.
28. Gerke JR, Magliocco MV. 1971. Experimental Pseudomonas aeruginosa infections of the mouse cornea. Infect Immun 3:209-216.
29. Gipson IK, Sugrue SP. 1994. Cell biology of the corneal epithelium. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders. p 3-16.
30. Goodwin FK, Gordis E. 1991. Correspondence. New Biologist 3:907-908.
31. Gupta SK, Berk RS, Masinick S, Hazlett LD. 1994. Pili and lipopolysaccharide of Pseudomonas aeruginosa bind to the glycolipid asialo GMI. Infect Immun 62:4572-4579.
32. Harrison SM. 1975. Grading corneal ulcers. Ann Ophthalmol 7:537-542.
33. Hazlett LD. 1995. Analysis of ocular microbial adhesion. Methods Enzymol 253:53-66.
34. Hazlett LD, Rosen D, Berk RS. 1976. Experimental eye infections caused by Pseudomonas aeruginosa. Ophthalmic Res 8:311-318.
35. Hazlett LD, Moon MM, Singh A, Berk RS, Rudner XL. 1991. Analysis of adhesion, piliation, protease production and ocular infectivity of several Pseudomonas aeruginosa strains. Curr Eye Res 10:351-362.
36. Henson PM, Johnston RB Jr. 1987. Tissue injury in inflammation. J Clin Invest 79:669-674.
37. Hobden JA, Rootman DS, O'Callaghan RJ, Hill JM. 1988. Ionophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas. Antimicrob Agents Chemother 32:978-981.
38. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. 1993. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res 12:461-467.
39. Holland SP, Pulido JS, Shires TK, Costerton JW. 1993. Pseudomonas aeruginosa ocular infections. In: Fick RB Jr, editor. Pseudomonas aeruginosa the Opportunist: Pathogenesis and Disease. Boca Raton: CRC Press, p 159-176.
40. Kernacki KA, Goebel DJ, Poosch MS, Hazlett LD. 1998. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection in mice. Infect Immun 66:376-379.
41. Kreger AS. 1983. Pathogenesis of Pseudomonas aeruginosa ocular diseases. Rev Infect Dis 5:S931-S935.
42. Lemp MA. 1990. Is the dry eye contact lens wearer at risk? Yes. Cornea 9:S48-S50.
43. Levine M, Serdarevic O. 1998. Gram positive organisms and ciprofloxacin in contact lens induced microbial keratitis. (Abstract). Invest Ophthalmol Vis Sci 39:S337.
44. Naquet R. 1993. Ethical and moral considerations in the design of experiments. Neuroscience 57:183-189.
45. Olsen BR, McCarthy MT. 1994. Molecular structure of the sciera, cornea and vitreous body. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders. p 38-63.
46. Parker J. 1994. Help from philosophy: Responding to the animal rights challenge. FASEB J 8:375-377.
47. Preston MJ, Fleiszig SMJ, Zaidi TS, Goldberg JB, Shortridge VD, Vasil ML, Pier GB. 1995. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun 63:3497-3501.
48. Russell WMS, Burch RL, editors. 1959. The Principles of Humane Experimental Technique. London: Methuen.
49. Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR, and the Microbial Keratitis Study Group. 1989. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. N Engl J Med 321:773-778.
50. Smolin G. 1987. The role of tears in the prevention of infections. Int Ophthalmol Clin 27:25-26.
51. Twining SS, Zhou X, Schulte DP, Wilson PM, Fish B, Moulder J. 1986. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis. Invest Ophthalmol Vis Sci 37:511-522.
52. van Klink F, Taylor WM, Alizadeh H, Jager MJ, van Rooijen N, Niederkorn JY. 1996. The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 37:1271-1281.
53. Wilhelmus KR. 1996. Bacterial keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and Immunity. St Louis: Mosby. p 970-1032.
54. Wilson LA. 1996. Biomaterials and ocular infection. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and Immunity. St Louis: Mosby. p 215-231.